Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Subject
???browse.menu.type???
???browse.menu.publicationcategory???
???browse.menu.wos???
???browse.menu.scopus???
???browse.menu.bap???
???browse.menu.ec???
???browse.menu.tubitak???
???browse.menu.language???
???browse.menu.accessrights???
???browse.menu.department???
Help
Language
Türkçe
English
Sign on to:
My DSpace
Receive email
updates
Edit Profile
DSpace
JSPUI
DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets
Learn More
Açık Erişim@BUU
Browsing by Author Gürel, S.
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 5 of 5
Issue Date
Title
Author(s)
2004-10
ALT flares and sustained ALT response in patients with HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS (R)), peginterferon alfa-2a (40KD) plus lamivudine or lamivudine alone
Piratvisuth, T.
;
Marcellin, P.
;
Lau, G.
;
Bonino, F.
;
Farci, P.
;
Hadziyannis, S.
;
Jin, R.
;
Lu, Z.M.
;
Germanidis, G.
;
Yurdaydın, C.
;
Diago, M.
;
Lai, M.Y.
;
Button, P.
;
Why, R.D.
;
Pluck, N.
;
Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.
;
Gürel, S.
2006-10
A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)
Yurdaydın, Cihan
;
Wedemeyer, Heiner
;
Dalekos, George
;
Erhardt, Alexander
;
Çakaloğlu, Y.
;
Değertekin, H.
;
Zeuzem, Stefan
;
Zachou, Kalliopi
;
Bozkaya, Hakan
;
Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Gastroenteroloji Bilim Dalı.
;
Gürel, S.
2003-10
A phase III, partially double-blinded study evaluating the efficacy and safety of peginterferon alfa-2a (40KD) (PEGASYS (R)) alone or in combination with lamivudine vs lamivudine in 546 patients with HBeAg-negative/anti-HBe-positive chronic hepatitis B.
Marcellin, P.
;
Lau, G.
;
Bonino, F.
;
Farci, P.
;
Hadziyannis, S.
;
Jin, R.
;
Lu, Z.
;
Piratvisuth, T.
;
Germanidis, G.
;
Yurdaydın, C.
;
Diago, M.
;
Lai, M.
;
Button, P.
;
Pluck, N.
;
Uludağ Üniversitesi/Tıp Fakültesi.
;
Gürel, S.
;
AAH-5364-2019
;
ABI-3764-2020
2004-10
Profound on-treatment viral suppression with peginterferon alfa-2a (40KD) (PEGASYS (R)) plus lamivudine combination therapy limits the development of YMDD mutations, but does not improve sustained response rates over peginterferon alfa-2a (40KD) alone
Germanidis, G.
;
Marcellin, P.
;
Lau, G.
;
Bonino, F.
;
Farci, P.
;
Hadziyannis, S.
;
Jin, R.
;
Yao, G.B.
;
Piratvisuth, T.
;
Yurdaydın, C.
;
Diago, M.
;
Lai, M.Y.
;
Popescu, M.
;
Pluck, N.
;
Uludağ Üniversitesi/Tıp Fakültesi.
;
Gürel, S.
1999
The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer
Uludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı.
;
Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı.
;
Gürel, S.
;
Dolar, Mahmut Enver
;
Yerci, Ömer
;
Samlı, B.
;
Öztürk, H.
;
Nak, Selim Giray
;
Gülten, Macit
;
Memik, Faruk
;
AAG-9177-2021